068760 — Celltrion Pharm Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Celltrion Pharm, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	34,579	25,960	21,265	21,966	38,752
Depreciation
Amortisation
Non-Cash Items	17,510	13,739	15,915	26,975	22,430
Unusual Items
Other Non-Cash Items
Changes in Working Capital	24,684	-61,163	-48,149	-12,446	2,999
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	93,151	-4,046	8,757	56,588	86,430
Capital Expenditures	-12,501	-6,286	-6,898	-5,983	-17,923
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-3,803	-8,280	2,677	-6,133	-39,616
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-16,304	-14,566	-4,221	-12,116	-57,539
Financing Cash Flow Items	-5,642	-6,059	-8,278	-8,410	-5,918
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-22,410	-30,181	-16,215	-18,706	-24,499
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	54,438	-48,795	-11,680	25,769	4,392